Science Explorer Back to mapMap
Discussion
Researcher · Sarah Cannon · United States

Stephanie Royer‐Joo

Stephanie Royer‐Joo publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology and HER2/EGFR in Cancer Research.

ORCID 0000-0003-4205-9927 OpenAlex
World rank
#623,809
of 7,710,434 ranked researchers
Rank in United States
#213,264
of 1,627,098
Works
65
Citations
1.2k
Citations per work
19.0
h-index
17
i10-index 25Top 30% in Oncology

What does Stephanie Royer‐Joo research?

Stephanie Royer‐Joo's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (3%).

Life Sciences23%Health Sciences61%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4061.4%
    1. Biochemistry, Genetics and Molecular Biology1319.7%
    2. Immunology and Microbiology23.3%
  1. Everything else1015.6%
  1. 1Oncology35% of their works
  2. 2Pulmonary and Respiratory Medicine22% of their works
  3. 3Molecular Biology16% of their works
  4. 4Cancer Research4% of their works
  5. 5Genetics4% of their works
  6. 6Immunology3% of their works

Research topics

Which keywords describe Stephanie Royer‐Joo's research?

The keywords of their largest research topics: Metastatic Breast Cancer, Breast Cancer, CDK4/6 Inhibitors, Chemotherapy, Palbociclib, Targeted Therapy, Chemotherapy-Induced Peripheral Neuropathy and Taxanes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Metastatic Breast Cancer272 topics
  2. Breast Cancer242 topics
  3. CDK4/6 Inhibitors151 topic
  4. Chemotherapy152 topics
  5. Palbociclib151 topic
  6. Targeted Therapy132 topics
  7. Chemotherapy-Induced Peripheral Neuropathy121 topic
  8. Taxanes121 topic
  9. HER291 topic
  10. Trastuzumab91 topic
  11. ALK Inhibitors81 topic
  12. EGFR Mutations81 topic
  13. Signaling81 topic
  14. mTOR81 topic
  15. Cetuximab61 topic
  16. KRAS Mutations61 topic
  17. Cancer Genomics51 topic
  18. Chronic Lymphocytic Leukemia51 topic
  19. Genomic Aberrations51 topic
  20. Mutational Signatures51 topic

Where does Stephanie Royer‐Joo work?

Stephanie Royer‐Joo's main affiliation in the publication record is Sarah Cannon, United States.

How many publications and citations does Stephanie Royer‐Joo have?

OpenAlex counts 65 works and 1,235 citations for Stephanie Royer‐Joo, an h-index of 17, ranking #623,809 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Stephanie Royer‐Joo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.